D. Granato et al., Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro, J PARENT EN, 24(2), 2000, pp. 113-118
Background: Numerous studies suggest that immune function may be compromise
d by lipid emulsions rich in polyunsaturated fatty acids (PUFAs). In our st
udy, we compared the effect of a new olive oil-based lipid Emulsion (ClinOl
eic) containing a moderate level of PUFAs, with emulsions based on soybean
oil (Intralipid or Ivelip), on immune functions of human cell in vitro. Met
hods: peripheral white blood cells were collected from healthy volunteers.
Lymphocyte proliferation was evaluated by [H-3]-thymidine incorporation aft
er stimulation with either phytohemagglutinin (PHA) or antibodies against T
-cell specific antigens. Lymphocytes subsets and T-cell activation markers
(CD25 and HLA-DR) were measured by flow cytometry. The release of cytokines
(interleukin [IL]-2, IL-1 beta, and tumor necrosis factor-alpha [TNF-cl])
was measured by enzyme-linked immunosorbent. assay (ELISA), after lymphocyt
es or monocytes/macrophages stimulation with PHA or lipopolysaccharide (LPS
). Results: A significant dose-dependent inhibition of thymidine incorporat
ion was observed with Intralipid and Ivelip (incorporation down to 39.9% of
control, p <.001) whereas ClinOleic showed no inhibitory effect. Activatio
n antigen expression on both CD4(+) and CD8(+) T-cells tended to decrease w
ith Intralipid (CD25: -53.4% on CD4(+) and -57.4% on CD8(+); HLA-DR: -61.5%
on CD4(+) and -58.5% on CD8(+)) but not with ClinOleic (from -2.9% for CD2
5 on CD4(+) to 16.7% for HLA-DR on CD4(+)). Intralipid decreased significan
tly IL-2 production (-39.0%, p <.05) whereas ClinOleic had little effect (-
13.0%, NS). Intralipid and ClinOleic tended to inhibit to a similar extent
the release of pro-inflammatory cytokines (TNF-alpha: -21.5% and -34.8%, IL
-1 beta: -45.1% and -40.3%; respectively). Conclusions: Our results suggest
that an olive oil-based lipid emulsion could modulate immune response sele
ctively, maintaining protective immunity and reducing inflammatory response
. Olive oil may offer an immunologically neutral alternative to soybean oil
for use in parenteral lipid emulsions.